BIORA THERAPEUTICS, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.71 USD | -0.39% |
|
+14.85% | -46.60% |
Chart calendar Biora Therapeutics, Inc.
368d6a4e93dab.TJXZffzl2P9HgUtary0YDbmm9QhEQjtt7UuypP-C-h0.FaOREImQooom1BIIyns1evfNsEw0Fwg6uHrc7sbRlCQP2OsymLWTxyDpfw~f79717a3a3c348f13c0eeb29b88e4a66
Upcoming events on Biora Therapeutics, Inc.
Past events on Biora Therapeutics, Inc.
| 26/03/2024 20:30 | Q4 2023 Earnings Call |
| 26/03/2024 20:05 | Q4 2023 Earnings Release |
| 28/02/2024 15:00 | Canaccord Genuity Capital Markets Inflammatory Bowel Disease Symposium |
| 29/01/2024 16:00 | H.C. Wainwright Virtual Conference |
| 13/11/2023 21:30 | Q3 2023 Earnings Call |
| 13/11/2023 21:05 | Q3 2023 Earnings Release |
| 03/10/2023 12:45 | European Association for the Study of Diabetes Meeting - Presentation No:635 |
| 13/09/2023 16:00 | H.C. Wainwright Global Investment Conference |
| 14/08/2023 21:30 | Q2 2023 Earnings Call |
| 14/08/2023 21:01 | Q2 2023 Earnings Release |
| 10/08/2023 17:30 | Canaccord Genuity Growth Conference |
| 14/06/2023 18:00 | Annual General Meeting |
| 15/05/2023 21:30 | Q1 2023 Earnings Call |
| 15/05/2023 21:05 | Q1 2023 Earnings Release |
| 30/03/2023 21:30 | Q4 2022 Earnings Call |
| 30/03/2023 21:01 | Q4 2022 Earnings Release |
| 20/01/2023 02:15 | American Gastroenterological Association Crohn & Colitis Congress - Abstract No: 3831565 |
| 20/01/2023 02:15 | American Gastroenterological Association Crohn & Colitis Congress - Abstract No: 3831579 |
| 18/12/2022 | Extraordinary Shareholders Meeting |
| 14/11/2022 21:30 | Q3 2022 Earnings Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 144 | 74,3 84,9 -12.52% | 60,6 0,00 - | 0,31 0,30 1.67% | 0,00 0,00 60% | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -186 -185 -0.92% | -116 -131 11.39% | -60,9 -67,5 9.82% | -66,6 -63,7 -4.53% | -75,4 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -195 -187 -4.34% | -118 -138 14.55% | -61,8 -61,2 -0.95% | -67,1 -65,8 -2.02% | -67,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -230 -202 -13.92% | -179 -156 -14.36% | -49,3 -33,2 -48.34% | -124 -122 -1.67% | -68,1 |
|
Net income Million USD | Released Forecast Spread | -148 | -193 -158 -22.35% | -247 -180 -37.68% | -38,2 -41,4 7.83% | -124 -122 -1.42% | -68,1 |
|
EPS USD | Released Forecast Spread | 0,00 | -175 -148 -18.46% | -64,3 -47,6 -34.91% | -5,00 -5,45 8.17% | -7,87 -8,09 2.66% | -1,46 |
| Announcement Date | 19/03/20 | 18/03/21 | 28/03/22 | 30/03/23 | 26/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 7,66 | 1,38 | 0,10 0,00 - | 0,08 0,10 -20% | 0,01 0,06 -74.55% | 0,00 0,02 -90% | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | |
|
EBITDA Million USD | Released Forecast Spread | -19,9 -18,7 -6.46% | -14,2 -19,9 28.59% | -13,9 -15,9 12.66% | -13,3 -17,5 23.94% | -14,8 -15,9 7.12% | -23,2 -15,3 -51.61% | -13,2 -15,7 15.75% | -14,9 | -17,5 | -20,1 | -22,8 | ||
|
EBIT Million USD | Released Forecast Spread | -20,2 -25,5 20.95% | -21,8 -22,5 3.28% | -14,2 -17,5 18.8% | -13,9 -14,6 4.88% | -13,5 -13,2 -2.43% | -23,3 -14,2 -63.96% | -13,3 -14,1 5.51% | ||||||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -82,9 -23,7 -250.04% | -13,8 -22,0 37.24% | -6,83 -23,2 70.54% | -14,7 -11,1 -32.58% | -13,2 -8,10 -63.09% | -17,8 -17,8 -0.07% | -73,5 -17,4 -323.07% | -15,7 -16,6 5.14% | -13,7 | -16,5 | -19,2 | -21,9 | |
|
Net income Million USD | Released Forecast Spread | -92,9 -25,2 -268.77% | -13,8 -23,4 40.87% | -5,51 -21,5 74.3% | -5,11 -14,0 63.34% | -13,7 -11,1 -23.62% | -17,8 -17,8 -0.04% | -73,5 -17,4 -323.07% | -15,4 -16,6 7.04% | -13,7 | -16,5 | -19,2 | -21,9 | |
|
EPS USD | Released Forecast Spread | -14,0 -4,00 -250% | -2,00 -3,13 36% | -0,75 -3,00 75% | -0,75 -1,88 60% | -1,64 -1,45 -13.49% | -1,59 -1,75 9.14% | -1,47 -1,60 8.13% | -4,89 -0,93 -428.65% | -0,62 -0,60 -4.2% | -0,45 | -0,46 | -0,52 | -0,49 |
| Announcement Date | 28/03/22 | 10/05/22 | 15/08/22 | 14/11/22 | 30/03/23 | 15/05/23 | 14/08/23 | 13/11/23 | 26/03/24 | - | - | - | - |
More events
Past sector events for Biora Therapeutics, Inc.
| 02/05/2024 21:05 | KURA ONCOLOGY, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:05 | ZYMEWORKS INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:02 | ARDELYX, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:01 | LONGBOARD PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:01 | ASCENDIS PHARMA A/S: Q1 2024 Earnings Release |
| 02/05/2024 21:00 | ULTRAGENYX PHARMACEUTICAL INC.: Q1 2024 Earnings Release |
| 02/05/2024 16:00 | GENMAB A/S: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | GERON CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | AGIOS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | BICYCLE THERAPEUTICS PLC: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BIOR Stock
- Calendar Biora Therapeutics, Inc.
